Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vipulbhai Sakhiya

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA Oncology|July 17, 2015
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and DabrafenibKenar D Jhaveri, Vipulbhai Sakhiya, Steven Fishbane
Kidney International|September 24, 2021
Immune checkpoint inhibitor-associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting SystemRimda Wanchoo, Vipulbhai Sakhiya, Kenar D Jhaveri
Clinical Kidney Journal|April 12, 2017
Pregnancy outcomes in women on hemodialysis: a national surveyMala Sachdeva, Valerie Barta, Jyotsana Thakkar, et al.
Kidney International|August 14, 2016
Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting SystemKenar D Jhaveri, Vipulbhai Sakhiya, Rimda Wanchoo, et al.
Kidney International Reports|January 11, 2018
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative ReviewKenar D Jhaveri, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
Kidney International Reports|June 15, 2026
AKI After Hepatic HistotripsySalman Bhutta, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
American Journal of Hematology|June 1, 2019
Ibrutinib induced acute tubular injury: A case series and review of the literatureSandhya Manohar, Anip Bansal, Rimda Wanchoo, et al.
Kidney International|January 10, 2014
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancerAzzour D Hazzan, Hitesh H Shah, Susana Hong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Serum potassium laboratory reference ranges influence provider treatment behaviors for hyperkalemiaJamie S Hirsch, Rushang Parikh, Safiya Richardson, et al.
Kidney International|August 19, 2020
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19Jia H Ng, Jamie S Hirsch, Rimda Wanchoo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA Oncology|July 17, 2015
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and DabrafenibKenar D Jhaveri, Vipulbhai Sakhiya, Steven Fishbane
Kidney International|September 24, 2021
Immune checkpoint inhibitor-associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting SystemRimda Wanchoo, Vipulbhai Sakhiya, Kenar D Jhaveri
Clinical Kidney Journal|April 12, 2017
Pregnancy outcomes in women on hemodialysis: a national surveyMala Sachdeva, Valerie Barta, Jyotsana Thakkar, et al.
Kidney International|August 14, 2016
Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting SystemKenar D Jhaveri, Vipulbhai Sakhiya, Rimda Wanchoo, et al.
Kidney International Reports|January 11, 2018
Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative ReviewKenar D Jhaveri, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
Kidney International Reports|June 15, 2026
AKI After Hepatic HistotripsySalman Bhutta, Rimda Wanchoo, Vipulbhai Sakhiya, et al.
American Journal of Hematology|June 1, 2019
Ibrutinib induced acute tubular injury: A case series and review of the literatureSandhya Manohar, Anip Bansal, Rimda Wanchoo, et al.
Kidney International|January 10, 2014
Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancerAzzour D Hazzan, Hitesh H Shah, Susana Hong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Serum potassium laboratory reference ranges influence provider treatment behaviors for hyperkalemiaJamie S Hirsch, Rushang Parikh, Safiya Richardson, et al.
Kidney International|August 19, 2020
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19Jia H Ng, Jamie S Hirsch, Rimda Wanchoo, et al.
Pageof 2